The global spina bifida treatment market is estimated to witness significant growth during the forecast period 2020-2026. Spina bifida is a type of neural defects that happens to infants. This defect happens to a developing baby, while in the womb when his/her spinal cord fails to develop or close properly. Growing cases of spina bifida among the infants and medical advancement are driving the growth of the global spina bifida treatment market. Neurostimulation therapy is one such therapy available for the treatment of spina bifida. The neurostimulation therapy is expected to be emerging therapy owing to its significant potential in pain relief by interrupting the pain signals traveling between the brain and the spinal cord.
Browse the full report description of "Global Spina Bifida Treatment Market Size, Share & Trends Analysis Report, by Type (Occulta, Closed neural tube defects, Meningocele, and Myelomeningocele), by Treatment (Surgery {Cesarean section, Suprapubic cystostomy, Spinal Surgery, Colostomy, and Others}, Medical Procedure {Urinary catheterization, Urinary diversion, Enema}, and Devices) and Forecast Period 2019-2025" at https://www.omrglobal.com/industry-reports/spina-bifida-treatment-market
Rising cases of spina bifida have led the demand for more potential and reliable pain management treatment, which in turn, will likely offer scope for neurostimulation therapy in the treatment of spina bifida. As per the Center for Disease Control and Prevention data (CDC), each year, in the US, about 1,645 babies are born with spina bifida. During 2006-2015, in China, a total of 2,029 cases of spina bifida were identified. Neuropathic pain is the most common in patients suffering from spinal cord injury and usually difficult to treat. Spinal cord stimulation is an emerging technique that can be preferably used in interdisciplinary pain treatment.
The main indications to use spinal cord stimulation include neuropathic pain conditions such as peripheral nerve injuries or complex regional pain syndrome (CRPS) or as well as mixed neuropathic conditions such as failed back surgery syndrome (FBSS). In spinal cord stimulation therapy, the electric pulses alter and mask the pain signals before they reach the brain. It is a small device, like a pacemaker that delivers electrical pulses to the spinal cord and thereby supports people to effectively manage their chronic pain and decrease their use of opioid medications.
However, additional research is required to find out more evidence of the potential effects of spinal cord stimulation in neuropathy pain management, which may support to leverage the adoption of this therapy for the condition. Apart from the neurostimulation therapy, in September 2019, the National Institute for Health and Care Excellence (NICE) talked about two techniques of spina bifida treatment, the first consisted of opening the womb through surgery and operating on the fetus, and the other involved using keyhole surgery to access the unborn baby.
Global Spina Bifida Treatment Market Segmentation
By Types
By Treatment
o Cesarean section
o Suprapubic cystostomy
o Spinal Surgery
o Colostomy
o Others
o Urinary catheterization
o Urinary diversion
o Enema
Global Spina Bifida Treatment Market – Segment by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/spina-bifida-treatment-market